Nutra Pharma Corp. (NPHC)

Market Cap	1.42M
Revenue (ttm)	247.77K
Net Income (ttm)	7.11M
Shares Out	7.10B
EPS (ttm)	0.00
PE Ratio	0.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500,000
Average Volume	153,018
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	n/a
Beta	30.49
RSI	62.81
Earnings Date	n/a

About Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain as...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPHC

Financial Performance

In 2021, Nutra Pharma's revenue was $97,735, an increase of 88.32% compared to the previous year's $51,897. Losses were -$13.10 million, 1602.5% more than in 2020.